These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 20363657

  • 1. Efficacy and safety of combining intra-articular methylprednisolone and anti-TNF agent to achieve prolonged remission in patients with recurrent inflammatory monoarthritis.
    Haroon M, O'Gradaigh D.
    Joint Bone Spine; 2010 May; 77(3):232-4. PubMed ID: 20363657
    [Abstract] [Full Text] [Related]

  • 2. A randomized, controlled study of a single intra-articular injection of etanercept or glucocorticosteroids in patients with rheumatoid arthritis.
    Bliddal H, Terslev L, Qvistgaard E, Konig M, Holm CC, Rogind H, Boesen M, Danneskiold-Samsøe B, Torp-Pedersen S.
    Scand J Rheumatol; 2006 May; 35(5):341-5. PubMed ID: 17062431
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare.
    Carubbi F, Zugaro L, Cipriani P, Conchiglia A, Gregori L, Danniballe C, Letizia Pistoia M, Liakouli V, Ruscitti P, Ciccia F, Triolo G, Masciocchi C, Giacomelli R.
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):252-66. PubMed ID: 26684633
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritis.
    Benucci M, Saviola G, Baiardi P, Manfredi M, Sarzi-Puttini P, Atzeni F.
    Int J Immunopathol Pharmacol; 2011 Jun; 24(1):269-74. PubMed ID: 21496415
    [Abstract] [Full Text] [Related]

  • 5. Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis.
    Furman BD, Mangiapani DS, Zeitler E, Bailey KN, Horne PH, Huebner JL, Kraus VB, Guilak F, Olson SA.
    Arthritis Res Ther; 2014 Jun 25; 16(3):R134. PubMed ID: 24964765
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?
    Fisher BA, Keat A.
    J Rheumatol; 2006 Oct 25; 33(10):1934-5. PubMed ID: 17014012
    [No Abstract] [Full Text] [Related]

  • 8. Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
    van Herwaarden N, den Broeder AA, Jacobs W, van der Maas A, Bijlsma JW, van Vollenhoven RF, van den Bemt BJ.
    Cochrane Database Syst Rev; 2014 Sep 29; (9):CD010455. PubMed ID: 25264908
    [Abstract] [Full Text] [Related]

  • 9. The economic burden of biological therapy in rheumatoid arthritis in clinical practice: cost-effectiveness analysis of sub-cutaneous anti-TNFalpha treatment in Italian patients.
    Benucci M, Li Gobbi F, Sabadini L, Saviola G, Baiardi P, Manfredi M.
    Int J Immunopathol Pharmacol; 2009 Sep 29; 22(4):1147-52. PubMed ID: 20074482
    [Abstract] [Full Text] [Related]

  • 10. Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice.
    Arends S, van der Veer E, Kamps FB, Houtman PM, Bos R, Bootsma H, Brouwer E, Spoorenberg A.
    Clin Exp Rheumatol; 2015 Sep 29; 33(2):174-80. PubMed ID: 25797228
    [Abstract] [Full Text] [Related]

  • 11. [New drugs and treatment strategies for rheumatoid arthritis].
    Fantini F.
    Recenti Prog Med; 2003 Sep 29; 94(9):361-79. PubMed ID: 12942798
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intra-articular therapy with tumor necrosis factor-α antagonists: an update.
    Bello S, Bonali C, Serafino L, Rotondo C, Terlizzi N, Lapadula G.
    Reumatismo; 2014 Mar 14; 65(6):257-63. PubMed ID: 24705028
    [Abstract] [Full Text] [Related]

  • 17. TNF-α antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis.
    Saraceno R, Pietroleonardo L, Mazzotta A, Zangrilli A, Bianchi L, Chimenti S.
    Expert Opin Biol Ther; 2013 Apr 14; 13(4):469-73. PubMed ID: 23157654
    [Abstract] [Full Text] [Related]

  • 18. Switching between biological agents.
    van Vollenhoven RF.
    Clin Exp Rheumatol; 2004 Apr 14; 22(5 Suppl 35):S115-21. PubMed ID: 15552524
    [Abstract] [Full Text] [Related]

  • 19. Predicting response to anti-TNF treatment in rheumatoid arthritis patients.
    Atzeni F, Antivalle M, Pallavicini FB, Caporali R, Bazzani C, Gorla R, Favalli EG, Marchesoni A, Sarzi-Puttini P.
    Autoimmun Rev; 2009 Mar 14; 8(5):431-7. PubMed ID: 19211043
    [Abstract] [Full Text] [Related]

  • 20. [Intra-articular therapy with infliximab in psoriatic arthritis: efficacy and safety in refractory monoarthritis].
    Bello S, Bonali C, Serafino L, Di Giuseppe P, Minosi A, Terlizzi N.
    Reumatismo; 2010 Mar 14; 62(1):46-50. PubMed ID: 20390117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.